Literature DB >> 17007018

H. pylori infection and reflux oesophagitis: a case-control study.

Rahim Masjedizadeh1, Eskandar Hajiani, Koorosh Moezardalan, Saeed Samie, Mohammad-Javad Ehsani-Ardakani, Ali Daneshmand, Mohammad-Reza Zali.   

Abstract

AIM: To examine the relationship between H. pylori and gastro-oesophageal reflux disease (GORD) in Iran.
METHODS: In this study 51 GORD patients (referred to endoscopy at Taleghani hospital) were compared with 49 age-sex matched controls. Diagnosis of H. pylori was made by gastric mucosal biopsy and rapid urease test (positive if the result of one or both diagnostic methods was positive). Updated Sydney system was used to report histopathological changes.
RESULTS: The frequency of H. pylori infection based on rapid urease test and histology was 88.2% (45) in patients and 77.6% (38) in controls, which showed no significant difference. The frequency of H. pylori infection was significantly higher in the antrum than in the corpus and cardia. The mean activity, inflammation, and gastritis scores were also higher in the antrum of patients than in the antrum of controls. The mean scores were significantly higher in the corpus of controls than in the corpus of patients. Diffuse active gastritis was observed in a significantly larger number of controls, while the frequency of diffuse chronic gastritis was higher in patients. There was no significant difference in the frequency of other histological findings between patients and controls.
CONCLUSION: H. pylori infection cannot prevent GORD in this region.

Entities:  

Mesh:

Year:  2006        PMID: 17007018      PMCID: PMC4088166          DOI: 10.3748/wjg.v12.i35.5658

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  42 in total

Review 1.  Review article: gastro-oesophageal reflux disease and Helicobacter pylori infection.

Authors:  N B Vakil
Journal:  Aliment Pharmacol Ther       Date:  2002-03       Impact factor: 8.171

Review 2.  Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review.

Authors:  Anan Raghunath; A Pali S Hungin; David Wooff; Susan Childs
Journal:  BMJ       Date:  2003-04-05

3.  Symposium: Helicobacter pylori and clinical risks--focus on gastro-oesophageal reflux disease.

Authors:  P Malfertheiner; H J O'Connor; R M Genta; P Unge; A T R Axon
Journal:  Aliment Pharmacol Ther       Date:  2002-06       Impact factor: 8.171

4.  Reflux esophagitis patients in Singapore have motor and acid exposure abnormalities similar to patients in the Western hemisphere.

Authors:  K Y Ho; J Y Kang
Journal:  Am J Gastroenterol       Date:  1999-05       Impact factor: 10.864

5.  Relationship between intestinal metaplasia of the gastro-oesophageal junction, Helicobacter pylori infection and gastro-oesophageal reflux disease: a prospective study.

Authors:  O Pieramico; M V Zanetti
Journal:  Dig Liver Dis       Date:  2000-10       Impact factor: 4.088

6.  Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects.

Authors:  Y Yamaji; T Mitsushima; H Ikuma; M Okamoto; H Yoshida; T Kawabe; Y Shiratori; K Saito; K Yokouchi; M Omata
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

7.  Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion.

Authors:  T Koike; S Ohara; H Sekine; K Iijima; Y Abe; K Kato; T Toyota; T Shimosegawa
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

8.  Oesophageal acid clearing: one factor in the production of reflux oesophagitis.

Authors:  C Stanciu; J R Bennett
Journal:  Gut       Date:  1974-11       Impact factor: 23.059

9.  Mechanisms of gastroesophageal reflux in patients with reflux esophagitis.

Authors:  W J Dodds; J Dent; W J Hogan; J F Helm; R Hauser; G K Patel; M S Egide
Journal:  N Engl J Med       Date:  1982-12-16       Impact factor: 91.245

10.  Treatment of ulcerative reflux oesophagitis with colloidal bismuth subcitrate in combination with cimetidine.

Authors:  M V Borkent; J A Beker
Journal:  Gut       Date:  1988-03       Impact factor: 23.059

View more
  1 in total

1.  Chronic mucosal inflammation of the gastric cardia in gastroesophageal reflux disease is not regulated by FOXP3-expressing T cells.

Authors:  Arne Kandulski; Thomas Wex; Doerthe Kuester; Klaus Mönkemüller; Ulrich Peitz; Albert Roessner; Peter Malfertheiner
Journal:  Dig Dis Sci       Date:  2009-02-26       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.